Literature DB >> 19306396

Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.

Seiko Ohno1, Futoshi Toyoda, Dimitar P Zankov, Hidetada Yoshida, Takeru Makiyama, Keiko Tsuji, Toshihiro Honda, Kazuhiko Obayashi, Hisao Ueyama, Wataru Shimizu, Yoshihiro Miyamoto, Shiro Kamakura, Hiroshi Matsuura, Toru Kita, Minoru Horie.   

Abstract

Long QT syndrome (LQTS) is an inherited disease involving mutations in the genes encoding a number of cardiac ion channels and a membrane adaptor protein. Among the genes that are responsible for LQTS, KCNE1 and KCNE2 are members of the KCNE family of genes, and function as ancillary subunits of Kv channels. The third KCNE gene, KCNE3, is expressed in cardiac myocytes and interacts with KCNQ1 to change the channel properties. However, KCNE3 has never been linked to LQTS. To investigate the association between KCNE3 and LQTS, we conducted a genetic screening of KCNE3 mutations and single nucleotide polymorphisms (SNPs) in 485 Japanese LQTS probands using DHPLC-WAVE system and direct sequencing. Consequently, we identified two KCNE3 missense mutations, located in the N- and C-terminal domains. The functional effects of these mutations were examined by heterologous expression systems using CHO cells stably expressing KCNQ1. One mutation, p.R99lambdaH was identified in a 76-year-old woman who suffered torsades de pointes (TdP) after administration of disopyramide. Another mutation, p.T4A was identified in a 16-year-old boy and 67-year-old woman. Although the boy carried another KCNH2 mutation, he was asymptomatic. On the other hand, the woman suffered from hypokalemia-induced TdP. In a series of electrophysiological analyses, the KCNQ1(Q1)+KCNE3(E3)-R99lambdaH channel significantly reduced outward current compared to Q1+E3-WT, though the current density of the Q1+E3-T4A channel displayed no statistical significance. This is the first report of KCNE3 mutations associated with LQTS. Screening for variants in the KCNE3 gene is of clinical importance for LQTS patients. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19306396     DOI: 10.1002/humu.20834

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  KCNE3 acts by promoting voltage sensor activation in KCNQ1.

Authors:  Rene Barro-Soria; Marta E Perez; H Peter Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

3.  Novel exon 1 protein-coding regions N-terminally extend human KCNE3 and KCNE4.

Authors:  Geoffrey W Abbott
Journal:  FASEB J       Date:  2016-05-09       Impact factor: 5.191

Review 4.  Atrial fibrillation: the role of common and rare genetic variants.

Authors:  Morten S Olesen; Morten W Nielsen; Stig Haunsø; Jesper H Svendsen
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

Review 5.  KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?

Authors:  Geoffrey W Abbott
Journal:  Expert Rev Clin Pharmacol       Date:  2013-01       Impact factor: 5.045

Review 6.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

7.  Targeted deletion of Kcne3 impairs skeletal muscle function in mice.

Authors:  Elizabeth C King; Vishal Patel; Marie Anand; Xiaoli Zhao; Shawn M Crump; Zhaoyang Hu; Noah Weisleder; Geoffrey W Abbott
Journal:  FASEB J       Date:  2017-03-29       Impact factor: 5.191

8.  Disruption of the K+ channel beta-subunit KCNE3 reveals an important role in intestinal and tracheal Cl- transport.

Authors:  Patricia Preston; Lena Wartosch; Dorothee Günzel; Michael Fromm; Patthara Kongsuphol; Jiraporn Ousingsawat; Karl Kunzelmann; Jacques Barhanin; Richard Warth; Thomas J Jentsch
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

9.  A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.

Authors:  Daniel C Bartos; Jeffrey B Anderson; Rachel Bastiaenen; Jonathan N Johnson; Michael H Gollob; David J Tester; Don E Burgess; Tessa Homfray; Elijah R Behr; Michael J Ackerman; Pascale Guicheney; Brian P Delisle
Journal:  J Cardiovasc Electrophysiol       Date:  2013-01-25

Review 10.  KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation.

Authors:  Geoffrey W Abbott
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.